Science
Powering forward – Genomics England’s COVID-19 response – Drug Target Review
Thorben Seeger reveals how Genomics England’s next-generation genomic research platform will play a key role in the response to COVID-19.
Posted: 11 September 2020 | Nikki Withers (Drug Target Review) | No comments yet
Genomics England has launched a next-generation genomic research platform that will play a key role in the response to COVID-19. It is hoped this research environment will transform how genomic data is made usable for global biopharma and academic scientists, providing worldclass patient data security, while enabling the flexibility required at the cutting edge of science. Nikki Withers spoke to Thorben Seeger, who…
-
Noosa News23 hours agoChild sex offenders to be known in Queensland public registry
-
General23 hours agoThousands flood cities demanding action on Palestine
-
General22 hours agoNRLW Sunday: Brisbane Broncos hammer Newcastle Knights, Cronulla Sharks move to third on ladder
-
General13 hours agoFirst home buyers score early access to deposit scheme